KCT0003177
Completed
未知
A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic Dermatitis
DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA0 sites14 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the skin and subcutaneous tissue
- Sponsor
- DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA
- Enrollment
- 14
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Age 20 and older, 50 and younger (excluded age of 50\)
- •(2\) Meeting the Hanifin and Rajka criteria, with Atopic Dermatitis symptoms appearing constantly for at least 3 months prior to study enrolment
- •(3\) SCORing Atopic Dermatitis (SCORAD) index score 10–40
- •(4\) Not taking prescription drugs for AD for at least 1 month prior to enrolment
- •(5\)Ability to understand the study protocol and to voluntarily agree to participate
- •(6\)Not participating in any other research studies for AD for at least 1 month prior to enrolment.
Exclusion Criteria
- •(1\) Severely fluctuating Atopic Dermatitis symptoms
- •(2\) Treatments that are not allowed in this study, for example, oral corticosteroids, which may affect the study outcomes
- •(3\) Asthma or bronchitis
- •(4\) Other disorders that may affect the outcomes, for example, anxiety or depression.
- •(5\) those who have a heart disease (such as heart failure, angina pectoris, Myocardial infarction)
- •(6\) Conceivable(Fertile) women who are Pregnant, lactating or not using proper method of contraception
- •(7\) those who are thought to be unable to participate in the study by the assessment of researchers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Vel Tooth powder against dental biofilm and Gingival bleeding among ChildreCTRI/2023/09/058077ational Institute of Siddha
Active, not recruiting
Not Applicable
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE
Not yet recruiting
Not Applicable
SIRT for metastatic pancreatic cancerACTRN12606000015549Sirtex Medical Limited10
Not yet recruiting
Phase 2
To evaluate the effectiveness of Amukkara chooranam and aya chenduram in the management of aan maladuHealth Condition 1: - Health Condition 2: - Health Condition 3: N461- OligospermiaCTRI/2024/04/065757DrSESWARI
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy and safety of R:GEN(Selective retina therapy) which induce to reduce drusen in patients with intermediate dry Age-related Macular DegeneratioDiseases of the eye and adnexaKCT0003227The Catholic University of Korea, Yeouido St. Mary's Hospital20